GET THE APP

Photophobia and Migraine Outcome during Treatment with Galca | 100768

Journal of Neurology & Neurophysiology

ISSN - 2155-9562

Abstract

Photophobia and Migraine Outcome during Treatment with Galcanezumab

Catherine Lapp*

The Calcitonin Gene-Related Peptide (CGRP), which affects both migraine pain and accompanying symptoms including photophobia, is crucial to the physiology of migraines. The current study sought to determine if monoclonal antibodies that target CGRP are effective in lowering ictal photophobia as well as headache and migraine frequency and disability.

Top